Central African Republic
Onchocerciasis is a country-wide public health problem in the Central African Republic.
People affected by onchocerciasis
- Number of communities in meso/hyper endemic (red) areas (2006): 5014
- Total population in meso/hyper endemic (red) areas (2006): 1 601 059
- Number of current community-directed treatment with ivermectin (CDTI) projects (2007): 1
- Date first community-directed treatment with ivermectin (CDTI) project was launched: 1998
- Number of national onchocerciasis task force (NOTF)-secretariat supported projects: 0
- Number of vector elimination projects: 0
NOTF-secretariat supported project is based at national level and is responsible for overseeing the implementation of all CDTI projects in the country and ensuring the availability of ivermectin.
- More about CDTI projects
- More about NOTF-secretariat supported projects
- More about vector elimination projects
Geographical coverage (2007)
- Number of communities treated with ivermectin: 3 195
- Treatment target (number of communities): 5 014
- Geographic coverage: 63.7%
Therapeutic coverage (2007)
- Number of people treated with ivermectin: 724 791
- Treatment target (number of people): 1 603 599
- Therapeutic coverage: 45.2%
- Number of trained or retrained community-directed distributors, CDDs (2007): 3 407
- Number of people per community-directed distributor, CDD (2007): 471
- Number of trained or retrained health workers (2007): 467
Projects are funded from three primary sources:
- the APOC Trust Fund
- the government of the country where the projects are being implemented
- funds from non-governmental development organization partners.
International non-governmental development organization (NGDO) partners (2007):
- Christoffel-Blindmission (CBM).